Up to 20% of BCs are neither detectable on mammograms nor properly identified [6]. Also, in the case of needle biopsies there is a relatively high percentage (up to 10%) of false negative results, delaying the moment of correct diagnosis [7]. Serum biomarkers, although they provide ...